About DocGo, Inc. 
DocGo, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 50 Schemes (26.44%)
Foreign Institutions
Held by 56 Foreign Institutions (4.98%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
80 Million
(Quarterly Results - Jun 2025)
Net Profit:
-13 Million
Pharmaceuticals & Biotechnology
USD 154 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.22
-9.71%
0.52






